Ignite Creation Date:
2024-05-06 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04692103
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-15
First Post:
2020-12-30
Brief Title:
Serial FES PETCT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy
Sponsor:
University of Washington
Organization:
University of Washington
Study Overview
Official Title:
Serial F-18 Fluoroestradiol FES PET Imaging to Evaluate Endocrine-targeted Therapy
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial studies use of F-18 16 alpha-fluoroestradiol F-18 FES positron emission tomography PETcomputed tomography CT in measuring tumor hormone receptor expression in patients undergoing endocrine-targeted therapy for newly diagnosed breast cancer or breast cancer that has come back or spread to other places in the body Comparing results of diagnostic procedures done before during and after hormone therapy may help measure a patients response to treatment
Detailed Description:
OUTLINE
Patients undergo F-18 FES PETCT scan at baseline Patients also undergo F-18 FES PETCT and FDG PETCT between 1-12 weeks after starting therapy and then 1-12 weeks after the second FES PETCT scan Repeat FDG PET may be omitted in patients on selective estrogen receptor degrader
After completion of study patients are followed up for up to 20 years
Patients undergo F-18 FES PETCT scan at baseline Patients also undergo F-18 FES PETCT and FDG PETCT between 1-12 weeks after starting therapy and then 1-12 weeks after the second FES PETCT scan Repeat FDG PET may be omitted in patients on selective estrogen receptor degrader
After completion of study patients are followed up for up to 20 years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 10465 | OTHER | Fred HutchUniversity of Washington Cancer Consortium | None |